Related Experiment Video
Updated: Jan 27, 2026

Surgical Models of Gastroesophageal Reflux with Mice
Published on: August 25, 2015
End-Stage Kidney Disease Following Reflux Nephropathy Since the 2011 AAP Guidelines
Craig Authement1,2, Poyyapakkam Srivaths2
1Division of Pediatric Nephrology, Department of Pediatrics, Baylor College of Medicine.
Insights
The American Academy of Pediatrics (AAP) guideline reduced voiding cysto-urethrogram (VCUG) use for febrile urinary tract infections (UTI) in children. Current data suggests this decrease has not led to harm, despite guideline retirement.
Area of Science:
- Pediatric Nephrology
- Diagnostic Imaging
- Clinical Practice Guidelines
Background:
- The 2011 American Academy of Pediatrics (AAP) guideline shifted imaging recommendations for pediatric febrile urinary tract infections (UTI).
- Voiding cysto-urethrogram (VCUG) was de-emphasized as a first-line study, with renal bladder ultrasound (RBUS) becoming the preferred initial imaging modality.
- The guideline aimed to reduce radiation exposure and discomfort for children while managing risks of high-grade vesico-ureteral reflux (VUR) or obstructive uropathy.
Purpose of the Study:
- To evaluate the impact of reduced voiding cysto-urethrogram (VCUG) utilization following the 2011 AAP guideline for febrile urinary tract infections (UTI) in children.
- To determine if the decreased use of VCUG has resulted in any adverse outcomes or harm to pediatric patients.
- To assess the current landscape of UTI imaging practices in children after the guideline's retirement in 2021.
Main Methods:
- Analysis of trends in voiding cysto-urethrogram (VCUG) utilization after the 2011 American Academy of Pediatrics (AAP) guideline for febrile urinary tract infections (UTI).
- Review of clinical outcomes and potential harms associated with the decreased use of VCUG in pediatric populations.
- Examination of current imaging practices in the post-guideline era, considering the guideline's retirement.
Main Results:
- The implementation of the 2011 AAP guideline led to a significant decrease in the use of voiding cysto-urethrogram (VCUG) for pediatric febrile urinary tract infections (UTI).
- Despite the reduction in VCUGs, available data does not indicate an increase in harm or missed diagnoses related to high-grade vesico-ureteral reflux (VUR) or obstructive uropathy.
- The proportion of children receiving VCUG remains low even after the guideline's retirement, suggesting a lasting shift in clinical practice.
Conclusions:
- The shift away from routine voiding cysto-urethrogram (VCUG) after febrile urinary tract infections (UTI) in children, as recommended by the 2011 AAP guideline, appears to be safe.
- The reduced utilization of VCUG has not demonstrably led to increased harm, supporting the guideline's approach of balancing diagnostic yield with procedural risks.
- Continued monitoring of imaging practices and patient outcomes in pediatric UTI is warranted, especially following the guideline's retirement.
Abstract:
In 2011, the American Academy of Pediatrics (AAP) published a clinical practice guideline for urinary tract infections (UTI) in which voiding cysto-urethrogram (VCUG) would no longer be the first-line imaging study after first febrile urinary tract infection in children.1 Instead, VCUG would be indicated if a renal bladder ultrasound (RBUS) reveals hydronephrosis, scarring, or other findings suggestive of high-grade vesico-ureteral reflux (VUR) or obstructive uropathy. RBUS was recommended for all febrile infants and could be done in the acute period if suppurative complications (eg, renal abscesses) were suspected. The guideline acknowledged that RBUS would not identify all children with high-grade VUR, but the risk of a missed case was low and balanced by the avoidance of a painful procedure that also involves radiation exposure. Subsequently, and as expected, the use of VCUGs has decreased. Even though the 2011 guideline was retired in 2021 as part of the AAP's work to eliminate race-based medicine, the proportion of children who receive a VCUG after a febrile UTI remains low. The question is whether this decrease in VCUG has led to any harm.
Related Concept Videos
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management

